Phenomenex wins R&D 100 Award
Phenomenex has received a 2010 R&D 100 award for its HPLC column technology. This marks the fifth consecutive year that the company has received the award.
Phenomenex has received a 2010 R&D 100 award for its HPLC column technology. This marks the fifth consecutive year that the company has received the award. According to president and CEO Fasha Mahjoor, “This reflects the depth of our product development pipeline and the fast pace at which we are able to bring new technologies to market.”
The awards, determined by an independent judging panel and the editors of R&D Magazine, recognize the 100 most technologically significant products introduced during the past year. Winners this year represent a broad range of industries and include well-known organizations such as Toyota Motor Corporation, Intel Corporation, Siemens Medical Solutions, NASA and 3M Company.
Talking about the column technology, Jeremy Bierman, brand manager for Phenomenex said that it “will have a profound impact on labs worldwide, especially where researchers face tight budgets and the need to quickly improve productivity.
“It has been exciting to hear how scientists are leveraging this technology in areas such as pharmaceutical development, clinical chemistry and food safety.”
For more information, visit www.phenomenex.com
Maximizing Cannabinoid Separation for Potency Testing with LC
April 7th 2025Researchers from the Department of Chemistry at Western Illinois University (Macomb, Illinois) conducted a study to optimize the separation of 18 cannabinoids for potency testing of hemp-based products, using liquid chromatography with a diode array detector (LC–DAD). As part of our monthlong series of articles pertaining to National Cannabis Awareness Month, LCGC International spoke to Liguo Song, the corresponding author of the paper stemming from this research, to discuss the study and its findings.
What Goes in a CDS IT Service Level Agreement?
April 7th 2025Protecting your network chromatography data system (CDS) data is critical and a service level agreement (SLA) with your IT provider is vital. What should be included? Are SLAs for in-house IT and SaaS (software as a service) similar?
